Evidence map›Paper›PMID 31673640›Full record

ArticleBMJ open quality2019

Optimisation of diagnosis and treatment of heart failure in a primary care setting.

Smita Bakhai, Aishwarya Bhardwaj, Huy Phan, Shane Varghese, Gregory D Gudleski, Jessica L Reynolds

Open access · goldAbstract read
In one paragraph

Article in BMJ open quality, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Smita BakhaiMedicine, Division of Internal Medicine, University at Buffalo-The State University of New York, Buffalo, New York, USA.
Aishwarya BhardwajMedicine, Division of Internal Medicine, University at Buffalo-The State University of New York, Buffalo, New York, USA.
Huy PhanMedicine, Division of Internal Medicine, University at Buffalo-The State University of New York, Buffalo, New York, USA.
Shane VargheseMedicine, Division of Internal Medicine, University at Buffalo-The State University of New York, Buffalo, New York, USA.
Gregory D GudleskiMedicine, Division of Behavioral Medicine, University at Buffalo-The State University of New York, Buffalo, New York, USA.
Jessica L ReynoldsMedicine, Divison of Allergy, Immunology & Rheumatology, University at Buffalo-The State University of New York, Buffalo, New York, USA.
University at Buffalo, State University of New York · US

Funding

University of Buffalo Clinical and Translational Science Institute - Supplement SchulyerUL1TR001412 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MURPHY, TIMOTHY F · 2015 to 2024
$33.8M
Pharmacokinetics and Immunodynamics of Immune stimulating chemotherapeuticnanoparticles for TBR01AI129649 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI REYNOLDS, JESSICA L · 2018 to 2022
$2.2M
NCATS NIH HHS UL1 TR001412NIAID NIH HHS R01 AI129649
6 · The paper itself

Abstract

backgroundHeart failure (HF) is one of the leading causes of emergency department visits and hospital admissions in the USA. We identified a gap in the diagnosis and the use of guideline-directed medical therapy in patients with HF at the internal medicine clinic.

aimTo improve the diagnosis and treatment of HF, as well as to reduce emergency department visits and hospitalisation over 12 months in patients aged 40-75 years.

methodsThe multidisciplinary quality improvement (QI) team performed a root cause analysis and identified barriers to optimal guideline-directed medical therapy. Rates of patients on guideline-directed medical therapy with systolic HF diagnosis, emergency department visits and hospital admissions were the outcome measures. The process measures included echocardiogram order and completion rates, and rates of accurate classification of HF from the baseline rate of less than 10%. We used the focus, analyse, develop, execute and evaluate (FADE) model with five improvement cycles. The major components of interventions included (1) leveraging health information technology; (2) optimising teamwork; and (3) providing education to patients, physicians and internal medicine clinic staff. Data were analysed using statistical process control and run charts.

resultsWe observed a reduction in the total number of emergency department visits (160 vs 108), hospital admissions (117 vs 114) and observation visits (22 vs 16) comparing the 1-year preproject and 1-year postproject periods. An increase in the use of ACE inhibitors or angiotensin receptor blockers occurred from the baseline rate of 20%-37% during the second half of the project and was sustained at 71.4% (median) during 6 months of the postproject period.

conclusionsWe achieved a sustainable increase in the accurate diagnosis of HF and achieved 80% diagnosis during the 6-month poststudy period.

Indexed as

guideline directed therapyHeart failureprimary carequality improvement

Identifiers

PMID31673640
PMCPMC6797327
OpenAlexW2981252954

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.